Displaying posts tagged with

“NK”

Autoimmune Disease, Chronic Fatigue Syndrome, Clinical Trials, Fibromyalgia, Medical Studies, Preventative No comments yet

Mushroom immunutrition in Chronic Fatigue Immune Dysfunction Syndrome

By on September 8th, 2010

In the recently published edition of the Journal of Integrated Medicine (Online version), Dr. Jean Monro of the Breakspear Hospital outlines the impact of Coriolus versicolor supplementation as immunonutrition in thirty-six (36) Chronic Fatigue Immune Dysfunction Syndrome (CFIDS) patients over a six week period.

1) Natural Killer Cells–before treatment the average NK cell level was average=129.64/mm3. After treatment this had increased to 175/mm3, an increase of 35%.

2) T cells (CD3 CD26)–there was increased activation in 66% of patients and T cell depression in 22% of patients. T cell level was unchanged in 11% of the patients. [...]

Continue reading →
Breast Cancer, Cancer, Cervical Cancer, Colorectal Cancer, Esophageal Cancer, Gastric Cancer, Human Papillomavirus (HPV), Immunotherapy, Lung Cancer, Lymphocytes, Medical Studies, News, PSK, PSP No comments yet

Coriolus Versicolor is Potent Mushroom for Fighting Cancer and Autoimmune Diseases – By: Barbara L. Minton, citizen journalist

By on September 3rd, 2010

(NaturalNews – January 28, 2009) Japanese researchers screened 200 of the best phytochemicals (plant extracts) known for anti-tumor activity. Coriolus versicolor was designated as exhibiting the greatest amount of anti-tumor activity. In another Japanese study, 185 people with lung cancer at different stages were given radiation. Doctors found those who also took Coriolus showed the best tumor shrinkage and the best survival rate. Another study involving stomach cancer patients produced similar results. Those who received Coriolus survived significantly longer, felt better and had fewer side effects. [...]

Continue reading →
Cancer, Cytokines, Interleukin, Leukemia, Lymphocytes, Lymphoma, Medical Studies, PSK, Why It Works No comments yet

Activation of human natural killer cells by the protein-bound polysaccharide PSK

By on September 2nd, 2010

The protein-bound polysaccharide PSK was tested for the ability to activate human natural killer (NK) cells. When blood lymphocytes and purified CD3-CD16 ÷ large granular lymphocytes (LGL) were treated in vitro overnight with PSK, they demonstrated enhanced NK cell activity against K562. The PSK-activated killer cells also [...]

Continue reading →